Work

Zumilokibart (APG777), a half-life extended monoclonal antibody, improves IL-13–driven airway pathology in preclinical asthma models

Year: 2026

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2026.pa2145

Authors: Kristie Barth, Kimberly Barker, Nolan Kearns, Grant Wickman, Lukas Dillinger

Language: English

Topic: Asthma and respiratory diseases

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7224401294

Cites:

Cited by:

Related to: 10